Corcept Announces Preliminary Results From Prevalence Phase

MENLO PARK, Calif., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the...

Related Keywords

United States ,Menlo Park ,California ,American ,Ralph Defronzo ,Corcept Therapeutics Incorporated ,Diabetes Division ,American Diabetes Association ,Ut Health San Antonio ,Drug Administration ,Development Officer ,Therapeutics Incorporated ,Scientific Sessions ,San Antonio ,Bill Guyer ,Chief Development ,Nasdaq Cort ,